In vitro methods to assess drug precipitation.
暂无分享,去创建一个
[1] H. Kristensen,et al. A dynamic in vitro lipolysis model. II: Evaluation of the model. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[2] Christos Reppas,et al. Forecasting the In Vivo Performance of Four Low Solubility Drugs from Their In Vitro Dissolution Data , 1999, Pharmaceutical Research.
[3] Vinod P. Shah,et al. The Role of Dissolution Testing in the Regulation of Pharmaceuticals: The FDA Perspective , 2005 .
[4] A Müllertz,et al. A dynamic in vitro lipolysis model. I. Controlling the rate of lipolysis by continuous addition of calcium. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[5] V. Jannin,et al. Approaches for the development of solid and semi-solid lipid-based formulations. , 2008, Advanced drug delivery reviews.
[6] W. Woltosz,et al. Predicting drug absorption by computational methods , 2002 .
[7] Ben J. Boyd,et al. Drug Solubilization Behavior During in Vitro Digestion of Simple Triglyceride Lipid Solution Formulations , 2004, Pharmaceutical Research.
[8] D. Hauss. Oral lipid-based formulations. , 2007, Advanced drug delivery reviews.
[9] Christos Reppas,et al. Dissolution media simulating the intralumenal composition of the small intestine: physiological issues and practical aspects , 2004, The Journal of pharmacy and pharmacology.
[10] S. Yalkowsky,et al. Evaluation of in vitro precipitation methods. , 1998, Journal of pharmaceutical sciences.
[11] G. Edwards,et al. Increasing the Proportional Content of Surfactant (Cremophor EL) Relative to Lipid in Self-emulsifying Lipid-based Formulations of Danazol Reduces Oral Bioavailability in Beagle Dogs , 2007, Pharmaceutical Research.
[12] B. Boyd,et al. Drug Solubilization Behavior During in Vitro Digestion of Suspension Formulations of Poorly Water-Soluble Drugs in Triglyceride Lipids , 2004, Pharmaceutical Research.
[13] S. Qureshi. Improved drug dissolution and product characterization using a crescent‐shaped spindle , 2004, The Journal of pharmacy and pharmacology.
[14] S. Yalkowsky,et al. Formulation-related problems associated with intravenous drug delivery. , 1998, Journal of pharmaceutical sciences.
[15] Jochem Alsenz,et al. Development of a partially automated solubility screening (PASS) assay for early drug development. , 2007, Journal of pharmaceutical sciences.
[16] Monique Alric,et al. A Dynamic Artificial Gastrointestinal System for Studying the Behavior of Orally Administered Drug Dosage Forms Under Various Physiological Conditions , 2004, Pharmaceutical Research.
[17] Qian Liu,et al. Evaluation of Dissolution Hydrodynamics in the USP, Peak™ and Flat-Bottom Vessels Using Different Solubility Drugs , 2005 .
[18] A. Straughn,et al. A high-throughput approach towards a novel formulation of fenofibrate in omega-3 oil. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[19] G. Edwards,et al. Evaluation of the impact of surfactant digestion on the bioavailability of danazol after oral administration of lipidic self-emulsifying formulations to dogs. , 2008, Journal of pharmaceutical sciences.
[20] J. Lindberg,et al. A collaborative in vitro dissolution study: comparing the flow-through method with the USP paddle method using USP prednisone calibrator tablets , 1989 .
[21] Bertil Abrahamsson,et al. Can the USP paddle method be used to represent in‐vivo hydrodynamics? , 2003, The Journal of pharmacy and pharmacology.
[22] Christopher T. Walsh,et al. Drugs as materials: valuing physical form in drug discovery , 2004, Nature Reviews Drug Discovery.
[23] Anette Müllertz,et al. In vivo in vitro correlations for a poorly soluble drug, danazol, using the flow-through dissolution method with biorelevant dissolution media. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[24] Colin Gardner. Drug candidate selection : The role of physical chemistry and material science in form and formulation , 2005 .
[25] Christopher J H Porter,et al. Lipid-based systems for the enhanced delivery of poorly water soluble drugs. , 2008, Advanced drug delivery reviews.
[26] Gary Eichenbaum,et al. Screening method to identify preclinical liquid and semi-solid formulations for low solubility compounds: miniaturization and automation of solvent casting and dissolution testing. , 2007, Journal of pharmaceutical sciences.
[27] Microparticulate-induced phlebitis. Its prevention by in-line filtration. , 1985 .
[28] S. Yalkowsky,et al. Studies in phlebitis. VI: Dilution-induced precipitation of amiodarone HCL. , 1993, Journal of parenteral science and technology : a publication of the Parenteral Drug Association.
[29] Ben J. Boyd,et al. Susceptibility to Lipase-Mediated Digestion Reduces the Oral Bioavailability of Danazol After Administration as a Medium-Chain Lipid-Based Microemulsion Formulation , 2004, Pharmaceutical Research.
[30] Samuel H. Yalkowsky,et al. Solubility and Solubilization in Aqueous Media , 1999 .
[31] Wei-Guo Dai,et al. Combination of Pluronic/Vitamin E TPGS as a potential inhibitor of drug precipitation. , 2008, International journal of pharmaceutics.
[32] Christos Reppas,et al. Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage Forms , 2004, Pharmaceutical Research.
[33] N. Muhammad,et al. Evaluation and Selection of Bio-relevant Dissolution Media for a Poorly Water-Soluble New Chemical Entity , 2001, Pharmaceutical development and technology.
[34] S. Yalkowsky,et al. Reformulation of a new vancomycin analog: An example of the importance of buffer species and strength , 2006, AAPS PharmSciTech.
[35] Christopher J H Porter,et al. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. , 2008, Advanced drug delivery reviews.
[36] G. Fisk,et al. Phlebitis and extravasation (“tissuing”) with intravenous infusions , 1984, The Medical journal of Australia.
[37] D. Adler,et al. Phenytoin sodium solubility in three intravenous solutions. , 1981, American journal of hospital pharmacy.
[38] Jon Hilden,et al. Using a novel multicompartment dissolution system to predict the effect of gastric pH on the oral absorption of weak bases with poor intrinsic solubility. , 2005, Journal of pharmaceutical sciences.
[39] James C. Sexton,et al. Simulating the hydrodynamic conditions in the united states pharmacopeia paddle dissolution apparatus , 2008, AAPS PharmSciTech.
[40] J. Phillips,et al. A Flow-Through Dissolution Approach to In Vivo/In Vitro Correlation of Adinazolam Release from Sustained Release Formulations , 1989 .
[41] C. Porter,et al. In vitro assessment of oral lipid based formulations. , 2001, Advanced drug delivery reviews.
[42] Hans Lennernäs,et al. The Effects of Food on the Dissolution of Poorly Soluble Drugs in Human and in Model Small Intestinal Fluids , 2005, Pharmaceutical Research.
[43] Erika S. Stippler,et al. Comparison of US Pharmacopeia Simulated Intestinal Fluid TS (without pancreatin) and Phosphate Standard Buffer pH 6.8, TS of the International Pharmacopoeia with Respect to Their Use in In Vitro Dissolution Testing , 2004 .
[44] P. Quist,et al. Dissolution of USP prednisone calibrator tablets: effects of stirring conditions and particle size distribution. , 2003, Journal of pharmaceutical and biomedical analysis.
[45] Ping Gao,et al. Characterization and optimization of AMG 517 supersaturatable self-emulsifying drug delivery system (S-SEDDS) for improved oral absorption. , 2009, Journal of pharmaceutical sciences.
[46] Tycho Heimbach,et al. Automated approach to couple solubility with final pH and crystallinity for pharmaceutical discovery compounds. , 2007, Journal of pharmaceutical and biomedical analysis.
[47] S. R. Cammarn,et al. Predicting dissolution via hydrodynamics: salicylic acid tablets in flow through cell dissolution. , 2000, International journal of pharmaceutics.
[48] Dissolution: Fundamentals of In Vitro Release and the Biopharmaceutics Classification System , 2007 .
[49] T Taniguchi,et al. Precipitate formed by thiopentone and vecuronium causes pulmonary embolism , 1998, Canadian journal of anaesthesia = Journal canadien d'anesthesie.
[50] A. Healy,et al. Hydrodynamic simulation (computational fluid dynamics) of asymmetrically positioned tablets in the paddle dissolution apparatus: impact on dissolution rate and variability , 2005, The Journal of pharmacy and pharmacology.
[51] Chris McNulty,et al. A High-Throughput Combinatorial Approach for the Discovery of a Cremophor EL-Free Paclitaxel Formulation , 2003, Pharmaceutical Research.
[52] G. Edwards,et al. Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine. , 2004, Journal of pharmaceutical sciences.
[53] Xinfeng Shi,et al. Evaluation of drug precipitation of solubility-enhancing liquid formulations using milligram quantities of a new molecular entity (NME). , 2007, Journal of pharmaceutical sciences.
[54] H. Möller,et al. Regulatory aspects of modified release dosage forms: special cases of dissolution testing using the flow-through system. , 1993, Bollettino chimico farmaceutico.
[55] C. Pouton,et al. KEY ISSUES WHEN FORMULATING HYDROPHOBIC DRUGS WITH LIPIDS , 1999 .
[56] S. Yalkowsky,et al. Estimation of drug precipitation upon dilution of pH-controlled formulations. , 2007, Molecular pharmaceutics.
[57] R. Strickley. Solubilizing Excipients in Oral and Injectable Formulations , 2004, Pharmaceutical Research.
[58] S. Valvani,et al. Precipitation of Drugs Due to Injection or Dilution , 1977 .
[59] J. Dressman,et al. Influence of Hydrodynamics and Particle Size on the Absorption of Felodipine in Labradors , 2004, Pharmaceutical Research.
[60] P. Armenante,et al. Velocity Distribution and Shear Rate Variability Resulting from Changes in the Impeller Location in the USP Dissolution Testing Apparatus II , 2008, Pharmaceutical Research.
[61] O. Almarsson,et al. Combined use of crystalline salt forms and precipitation inhibitors to improve oral absorption of celecoxib from solid oral formulations. , 2007, Journal of pharmaceutical sciences.
[62] H. Derendorf,et al. In vivo-in vitro correlations of salicylate saliva levels and continuous flow cell dissolution rates , 1983 .
[63] E. A. Nunan,et al. Optimization and statistical evaluation of dissolution tests for indinavir sulfate capsules. , 2004, Farmaco.
[64] Jonathan Kenneth Embleton,et al. Influence of lipolysis on drug absorption from the gastro-intestinal tract , 1997 .
[65] Matt Peterson,et al. Application of high throughput technologies to drug substance and drug product development , 2004, Comput. Chem. Eng..
[66] J. Kovach,et al. Regional targeting of Bisantrene by directed intravascular precipitation , 2004, Cancer Chemotherapy and Pharmacology.
[67] A. Serajuddin,et al. Physicochemical basis of increased bioavailability of a poorly water-soluble drug following oral administration as organic solutions. , 1988, Journal of pharmaceutical sciences.
[68] Anne Marie Healy,et al. Evaluation of hydrodynamics in the basket dissolution apparatus using computational fluid dynamics--dissolution rate implications. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[69] S. Qureshi. Comparative Impact of Stirring and Shearing in Drug Dissolution Testing with USP Paddle and Crescent-Shaped Spindles , 2006 .
[70] C. Porter,et al. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs , 2007, Nature Reviews Drug Discovery.
[71] Jean-Francois Marier,et al. A Novel, Lipid-Free Nanodispersion Formulation of Propofol and Its Characterization , 2005, Pharmaceutical Research.
[72] Arik Dahan,et al. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[73] Jackie Butler,et al. Influence of dissolution medium buffer composition on ketoprofen release from ER products and in vitro-in vivo correlation. , 2003, International journal of pharmaceutics.
[74] H. Kristensen,et al. Solubilisation of poorly water-soluble drugs during in vitro lipolysis of medium- and long-chain triacylglycerols. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[75] Wei-Guo Dai,et al. Advanced screening assays to rapidly identify solubility-enhancing formulations: high-throughput, miniaturization and automation. , 2008, Advanced drug delivery reviews.
[76] K. Thoma,et al. Development of an automated flow-through dissolution system for poorly soluble drugs with poor chemical stability in dissolution media , 1998 .
[77] S. Yalkowsky,et al. Precipitation of pH solubilized phenytoin , 1994 .
[78] R G Ulrich,et al. Plasma compatibility of injectables: comparison of intravenous U-74006F, a 21-aminosteroid antioxidant, with Dilantin brand of parenteral phenytoin. , 1991, Journal of pharmaceutical sciences.
[79] D. M. Simmons. Characterization of the Precipitates of Poorly Water Soluble Drugs and Determination of the Solubilities in Human Gastro-Intestinal Fluids by Microsopy , 1993 .
[80] Kevin C. Johnson,et al. Dissolution and Absorption Modeling: Model Expansion to Simulate the Effects of Precipitation, Water Absorption, Longitudinally Changing Intestinal Permeability, and Controlled Release on Drug Absorption , 2003, Drug development and industrial pharmacy.
[81] J. Dressman,et al. Forecasting the Oral Absorption Behavior of Poorly Soluble Weak Bases Using Solubility and Dissolution Studies in Biorelevant Media , 2002, Pharmaceutical Research.
[82] J. Dressman,et al. Predicting the precipitation of poorly soluble weak bases upon entry in the small intestine , 2004, The Journal of pharmacy and pharmacology.
[83] Jing Chen,et al. Parallel screening approach to identify solubility-enhancing formulations for improved bioavailability of a poorly water-soluble compound using milligram quantities of material. , 2007, International journal of pharmaceutics.
[84] Samuel H Yalkowsky,et al. Estimation of drug precipitation upon dilution of pH-cosolvent solubilized formulations. , 2007, Chemical & pharmaceutical bulletin.
[85] S E Tabibi,et al. Parenteral formulation of Flavopiridol (NSC-649890). , 1996, PDA journal of pharmaceutical science and technology.
[86] S. Yalkowsky,et al. Prediction of precipitation-induced phlebitis: a statistical validation of an in vitro model. , 2003, Journal of pharmaceutical sciences.
[87] Abu T.M. Serajuddin,et al. Lipid-Based Self-Emulsifying Solid Dispersions , 2007 .
[88] F J Muzzio,et al. Shear distribution and variability in the USP Apparatus 2 under turbulent conditions. , 2004, International journal of pharmaceutics.
[89] A. Hoffman,et al. Use of a Dynamic in Vitro Lipolysis Model to Rationalize Oral Formulation Development for Poor Water Soluble Drugs: Correlation with in Vivo Data and the Relationship to Intra-Enterocyte Processes in Rats , 2006, Pharmaceutical Research.
[90] D. Fatouros,et al. In vitro lipid digestion models in design of drug delivery systems for enhancing oral bioavailability , 2008, Expert opinion on drug metabolism & toxicology.
[91] L H Emara,et al. In Vitro-In Vivo Correlation and Comparative Bioavailablity of Vincamine in Prolonged-Release Preparations , 2000, Drug development and industrial pharmacy.
[92] Nagesh R Palepu,et al. Assessment of oral bioavailability enhancing approaches for SB-247083 using flow-through cell dissolution testing as one of the screens. , 2003, International journal of pharmaceutics.
[93] K. Iseki,et al. Development of a new system for prediction of drug absorption that takes into account drug dissolution and pH change in the gastro-intestinal tract. , 2001, International journal of pharmaceutics.
[94] J. Lindberg,et al. A collaborative in vitro dissolution study using the flow-through method , 1987 .
[95] Kevin C. Johnson,et al. Dissolution Modeling: Factors Affecting the Dissolution Rates of Polydisperse Powders , 1993, Pharmaceutical Research.
[96] S. Yalkowsky,et al. Studies in phlebitis. V: Hemolysis as a model for phlebitis. , 1993, Journal of parenteral science and technology : a publication of the Parenteral Drug Association.
[97] J. Reymond,et al. In Vivo Model for Ciclosporin Intestinal Absorption in Lipid Vehicles , 1988, Pharmaceutical Research.
[98] James C. Sexton,et al. Computational fluid dynamics modeling of the paddle dissolution apparatus: Agitation rate, mixing patterns, and fluid velocities , 2004, AAPS PharmSciTech.
[99] Srini Venkatesh,et al. Miniature Device for Aqueous and Non-aqueous Solubility Measurements During Drug Discovery , 2004, Pharmaceutical Research.
[100] Turco Sj. Phlebitis associated with intravenous drug administration. , 1975 .
[101] Christopher J H Porter,et al. Evaluation of the in‐vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products , 2002, The Journal of pharmacy and pharmacology.
[102] C. Pouton,et al. Enhancing intestinal drug solubilisation using lipid-based delivery systems. , 2008, Advanced drug delivery reviews.
[103] Manfred Kansy,et al. High throughput solubility measurement in drug discovery and development. , 2007, Advanced drug delivery reviews.
[104] M. Gentzler,et al. Hydrodynamic investigation of USP dissolution test apparatus II. , 2007, Journal of pharmaceutical sciences.
[105] Kiyohiko Sugano,et al. High throughput solubility measurement with automated polarized light microscopy analysis. , 2006, Journal of pharmaceutical sciences.
[106] B. Boyd,et al. Examination of the impact of a range of Pluronic surfactants on the in‐vitro solubilisation behaviour and oral bioavailability of lipidic formulations of atovaquone , 2006, The Journal of pharmacy and pharmacology.
[107] Betty-ann Hoener and Leslie Z.Benet. Factors Influencing Drug Absorption and Drug Availability , 2002 .
[108] J. Kovach,et al. Disposition of bisantrene in humans and rabbits: evidence for intravascular deposition of drug as a cause of phlebitis. , 1983, Cancer research.
[109] Masao Kobayashi,et al. Prediction of in vivo drug release behavior of controlled-release multiple-unit dosage forms in dogs using a flow-through type dissolution test method. , 2003, International journal of pharmaceutics.
[110] S. Yalkowsky,et al. In vitro method for detecting precipitation of parenteral formulations after injection. , 1983, Journal of pharmaceutical sciences.
[111] Fernando J Muzzio,et al. Hydrodynamics-induced variability in the USP apparatus II dissolution test. , 2005, International journal of pharmaceutics.
[112] D. Burgess,et al. Application of USP Apparatus 4 and In Situ Fiber Optic Analysis to Microsphere Release Testing , 2005 .
[113] S. Yalkowsky,et al. Buffer capacity and precipitation control of pH solubilized phenytoin formulations. , 1999, International journal of pharmaceutics.
[114] R. Neubert,et al. Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[115] V R Uppoor,et al. Regulatory perspectives on in vitro (dissolution)/in vivo (bioavailability) correlations. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[116] S. Qureshi,et al. Application of flow-through dissolution method for the evaluation of oral formulations of nifedipine , 1994 .
[117] S H Yalkowsky,et al. Studies in phlebitis. IV: Injection rate and amiodarone-induced phlebitis. , 1993, Journal of parenteral science and technology : a publication of the Parenteral Drug Association.
[118] Arik Dahan,et al. The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[119] P Li,et al. Evaluation of intravenous flavopiridol formulations. , 1999, PDA journal of pharmaceutical science and technology.
[120] S. Walker,et al. Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964-1985). , 1988, British journal of clinical pharmacology.
[121] Jochem Alsenz,et al. Miniaturized Assay for Solubility and Residual Solid Screening (SORESOS) in Early Drug Development , 2007, Pharmaceutical Research.
[122] R. Löbenberg,et al. Evaluation of Various Dissolution Media for Predicting In Vivo Performance of Class I and II Drugs , 1998, Pharmaceutical Research.
[123] W. J. Irwin,et al. Bropirimine formulation : the dynamic testing of injections , 1992 .
[124] J. Dressman,et al. In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[125] C. Pouton,et al. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.